SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-20-009534
Filing Date
2020-06-16
Accepted
2020-06-16 16:26:32
Documents
8
Period of Report
2020-06-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crdf8-k061620.htm 8-K 52972
2 EX-3.1 a31crdf061620.htm EX-3.1 147233
3 EX-4.1 a41crdf061620.htm EX-4.1 222698
4 EX-5.1 a51crdf061620.htm EX-5.1 16125
5 EX-10.1 a101crdf061620.htm EX-10.1 450315
6 EX-99.1 a991crdf061620.htm EX-99.1 19637
7 cardifflogorgbtm11.jpg GRAPHIC 176318
8 image01.jpg GRAPHIC 50931
  Complete submission text file 0001628280-20-009534.txt   1208865
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

IRS No.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35558 | Film No.: 20966754
SIC: 2836 Biological Products, (No Diagnostic Substances)